PPHM - Press ReleaseSource: Peregrine Pharmaceuticals, Inc.
Peregrine Regains Compliance with Nasdaq Listing Requirements
Thursday June 12, 10:30 am ET
TUSTIN, Calif., June 12 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals (Nasdaq: PPHM - News) today announced that it has been notified by the Nasdaq Stock Market that it has regained full compliance with the Nasdaq SmallCap listing requirements as a result of the closing bid price of its common stock having been at or above the minimum requirement of $1.00 per share for at least 10 consecutive trading days.
Alt Text"Although the company was in compliance with the minimum bid price rules under the temporary pilot program initiated by the Nasdaq Stock Market in January 2003, we are pleased to regain full compliance and to maintain our trading status on the Nasdaq SmallCap Market," said Steven King, president and CEO of Peregrine.
Songs I Luv
( NEWER )
( NEW )